Observational studyPloS one2026
Seasonal variation in the incidence of vitreous hemorrhage in proliferative diabetic retinopathy.
Observational study in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate whether seasonal alterations and meteorological factors are associated with the incidence of vitreous hemorrhage in patients with proliferative diabetic retinopathy (PDR). MATERIALS AND
methodsThis retrospective observational study included patients with PDR who visited Seoul St. Mary's Hospital between January 2019 and December 2021. Among the 4,402 eyes with PDR, the presence of vitreous hemorrhage was determined. The monthly incidence of vitreous hemorrhage and meteorological data were obtained and analyzed.
resultsAmong 4,402 eyes of PDR, vitreous hemorrhage was observed in 293 eyes (6.66%). The incidence of vitreous hemorrhage was high in May (9.37%, 31 of 331 eyes) and June (8.58%, 26 of 303 eyes). Poisson regression analyses revealed that temperature, humidity, and precipitation-per-hour did not influence the risk of vitreous hemorrhage. Thus, the observed seasonal variation in vitreous hemorrhage was not fully explained by the measured meteorological factors. The Wilcoxon signed-rank test revealed a significant difference between the intraocular pressure (IOP) at the time of hemorrhage (hemorrhage-IOP; hot season) and IOP at the visit immediately before the occurrence of hemorrhage (pre-IOP; cold season) groups (P = .029) and between the hemorrhage-IOP (warm season) and pre-IOP (cold season) groups (P = .041).
conclusionVitreous hemorrhage in PDR showed seasonal variations, peaking in May and June. This pattern could not be fully explained by the meteorological variables evaluated; IOP-fluctuations caused by temperature changes and systemic factors such as seasonal changes in glycemic control may contribute to this variability. Further studies are warranted to elucidate the underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.